Form 4: Zimmer Biomet Executive Lori Winkler Reports Stock Transactions

Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Lori Winkler, a Senior Vice President and CHRO at Zimmer Biomet Holdings, Inc., filed a Form 4 detailing changes in her beneficial ownership of company stock.
• On February 25, 2024, Winkler vested 1,294 restricted stock units (RSUs), which converted into an equal number of common stock shares.
• Also on February 25, 2024, 351 shares were withheld by Zimmer Biomet to satisfy tax obligations related to the RSU vesting at a price of $128.8.
• Following these transactions, Winkler directly owns 1,310 shares of Zimmer Biomet common stock.
• The reported transactions also reflect adjustments to the RSUs that occurred on March 1, 2022, related to the spinoff of Zimvie Inc., where the RSUs were adjusted to preserve their intrinsic value.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices and tax obligation fulfillment.

Key Dates